Detection of apoptotic cells in a rabbit model with atherosclerosis-like lesions using the positron emission tomography radiotracer [18F]ML-10

Molecular Imaging

Volumn 14, Issue 7, 2015, Pages 433-442

  Hyafil, Fabien ^a   Tran Dinh, Alexy ^a   Burg, Samuel ^a   Leygnac, Sébastien ^a   Louedec, Liliane ^a   Milliner, Milan ^a   Azzouna, Rana Ben ^a   Reshef, Ayelet ^a   Ami, Miri Ben ^a   Meilhac, Olivier ^a   Le Guludec, Dominique ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; CELL DEATH; POSITRONS; RADIOACTIVE TRACERS; RADIOGRAPHY;

APOPTOTIC CELLS; ATHEROSCLEROTIC PLAQUE; BACKGROUND RATIO; GAMMA-COUNTING; METHYLMALONIC ACID; POSITRON EMISSION TOMOGRAPHY (PET); RABBIT MODELS; STRONG CORRELATION;

POSITRON EMISSION TOMOGRAPHY;

5-FLUOROPENTYL-2-METHYLMALONIC ACID; FLUORINE; METHYLMALONIC ACID; RADIOPHARMACEUTICAL AGENT;

ANALOGS AND DERIVATIVES; ANIMAL; AORTA; ATHEROSCLEROSIS; DISEASE MODEL; INJECTION; MALE; METABOLISM; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RABBIT; SCINTISCANNING;

ANIMALS; AORTA; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; FLUORINE RADIOISOTOPES; INJECTIONS; MALE; METHYLMALONIC ACID; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RADIOPHARMACEUTICALS;

EID: 84942899519     PISSN: 15353508     EISSN: 15360121     Source Type: Journal    
DOI: 10.2310/7290.2015.00017     Document Type: Article

References (30)

1. Cohen A, Shirvan A, Levin G, et al. From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res 2009;19:625-37, doi:10.1038/cr.2009.17.
2. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: The Oxford plaque study. Circulation 2006;113:2320-8, doi:10.1161/CIRCULATION AHA.105.589044.
3. Kockx MM, Herman AG. Apoptosis in atherogenesis: implications for plaque destabilization. Eur Heart J 1998;19 Suppl G:G23-8.
4. Yuan C, Mitsumori LM, Ferguson MS, et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipidrich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 2001;104:2051-6, doi:10.1161/hc4201.097839.
5. Laufer EM, WinkensMH, Narula J, Hofstra L.Molecular imaging of macrophage cell death for the assessment of plaque vulnerability. Arterioscler Thromb Vasc Biol 2009;29:1031-8, doi:10.1161/ATVBAHA.108.165522.
6. Hyafil F, Cornily J, Feig J, et al. In vivo non invasive detection of macrophages using computed tomography and a specific contrast agent. Nat Med 2007;13:636-41, doi:10.1038/nm1571.
7. Hyafil F, Cornily JC, Rudd JH, et al. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: A comparison with 18F-FDG PET/CT and histology. J Nucl Med 2009;50:959-65, doi:10.2967/jnumed. 108.060749.
8. Reshef A, Shirvan A, Waterhouse RN, et al. Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET. J Nucl Med 2008;49:1520-8, doi:10.2967/jnumed.107.043919.
9. Rudd JH, Hyafil F, Fayad ZA. Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol 2009;29:1009-16, doi:10.1161/ATVBAHA.108.165563.
10. Joshi F, Rosenbaum D, Bordes S, Rudd JH. Vascular imaging with positron emission tomography. J Intern Med 2011;270:99-109, doi:10.1111/j.1365-2796.2011.02392.x.
11. Hyafil F, Feldman L, Le Guludec D, Fayad ZA. Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography. Mt Sinai J Med 2012;79:689-704, doi:10.1002/msj.21349.
12. Tavakoli S, Vashist A, Sadeghi MM. Molecular imaging of plaque vulnerability. J Nucl Cardiol 2014;21:1112-28, doi:10.1007/s12350- 014 -9959-4.
13. Yun M, Yeh D, Araujo LI, et al. F-18 FDG uptake in the large arteries: A new observation. Clin Nucl Med 2001;26:314-9, doi: 10.1097/00003072-200104000-00007.
14. Yun M, Araujo D, Yeh A, et al. F-18 uptake in large arteries. Eur J Nucl Med 2001;26:314-9.
15. Tawakol A, Migrino RQ, Hoffmann U, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 2005;12:294-301, doi:10.1016/j.nuclcard.2005.03.002.
16. Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18Ffluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818-24, doi:10.1016/j. jacc.2006.05.076.
17. Davies JR, Rudd JH, Fryer TD, et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 2005;36:2642-7, doi:10.1161/01.STR. 0000190896.67743.b1.
18. Joshi NV, Vesey AT, Williams MC, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 2014;383:705-13, doi:10.1016/S0140-6736(13)61754-7.
19. Kolodgie FD, Petrov A, Virmani R, et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: A technique with potential for noninvasive imaging of vulnerable plaque. Circulation 2003;108:3134-9, doi:10.1161/01. CIR.0000105761.00573.50.
20. Johnson LL, Schofield L, Donahay T, et al. 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med 2005;46:1186-93.
21. Kietselaer BL, Reutelingsperger CP, Heidendal GA, et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 2004;350:1472-3, doi:10.1056/NEJM200404013501425.
22. Yagle KJ, Eary JF, Tait JF, et al. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J Nucl Med 2005;46:658-66.
23. Wangler C, Wangler B, Lehner S, et al. A universally applicable 68Ga-labeling technique for proteins. J Nucl Med 2011;52:586-91, doi:10.2967/jnumed.110.082198.
24. Sarda-Mantel L, Michel JB, Rouzet F, et al. (99m)Tc-annexin V and (111)In-antimyosin antibody uptake in experimental myocardial infarction in rats. Eur J Nucl Med Mol Imaging 2006;33:239-45, doi:10.1007/s00259-005-1900-2.
25. Reshef A, Shirvan A, Akselrod-Ballin A, et al. Small-molecule biomarkers for clinical PET imaging of apoptosis. J Nucl Med 2010;51:837-40, doi:10.2967/jnumed.109.063917.
26. Grimberg H, Levin G, Shirvan A, et al. Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis. Apoptosis 2009;14:257-67, doi:10.1007/s10495-008-0293-7.
27. Damianovich M, Ziv I, Heyman SN, et al. ApoSense: A novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis. Eur J Nucl Med Mol Imaging 2006;33:281-91, doi:10.1007/s00259-005-1905-x.
28. Hoglund J, Shirvan A, Antoni G, et al. 18F-ML-10, a PET tracer for apoptosis: first human study. J Nucl Med 2011;52:720-5, doi:10. 2967/jnumed.110.081786.
29. Oborski MJ, Laymon CM, Lieberman FS, et al. First use of (18)Flabeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy. Brain Behav 2014;4:312-5, doi:10.1002/brb3.217.
30. Burg S, Dupas A, Stute S, et al. Partial volume effect estimation and correction in the aortic vascular wall in PET imaging. Phys Med Biol 2013;58:7527-42, doi:10.1088/0031-9155/58/21/7527. 442 Hyafil.